UniProt ID | R113A_HUMAN | |
---|---|---|
UniProt AC | O15541 | |
Protein Name | RING finger protein 113A | |
Gene Name | RNF113A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 343 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MAEQLSPGKAVDQVCTFLFKKPGRKGAAGRRKRPACDPEPGESGSSSDEGCTVVRPEKKRVTHNPMIQKTRDSGKQKAAYGDLSSEEEEENEPESLGVVYKSTRSAKPVGPEDMGATAVYELDTEKERDAQAIFERSQKIQEELRGKEDDKIYRGINNYQKYMKPKDTSMGNASSGMVRKGPIRAPEHLRATVRWDYQPDICKDYKETGFCGFGDSCKFLHDRSDYKHGWQIERELDEGRYGVYEDENYEVGSDDEEIPFKCFICRQSFQNPVVTKCRHYFCESCALQHFRTTPRCYVCDQQTNGVFNPAKELIAKLEKHRATGEGGASDLPEDPDEDAIPIT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEQLSPGK ------CCCCCCCCH | 17.16 | 21406692 | |
6 | Phosphorylation | --MAEQLSPGKAVDQ --CCCCCCCCHHHHH | 31.16 | 29255136 | |
16 | Phosphorylation | KAVDQVCTFLFKKPG HHHHHHHHHHCCCCC | 25.23 | 28464451 | |
43 | Phosphorylation | CDPEPGESGSSSDEG CCCCCCCCCCCCCCC | 50.30 | 21955146 | |
45 | Phosphorylation | PEPGESGSSSDEGCT CCCCCCCCCCCCCCC | 35.63 | 21955146 | |
46 | Phosphorylation | EPGESGSSSDEGCTV CCCCCCCCCCCCCCE | 45.38 | 21955146 | |
47 | Phosphorylation | PGESGSSSDEGCTVV CCCCCCCCCCCCCEE | 41.18 | 21955146 | |
52 | Phosphorylation | SSSDEGCTVVRPEKK CCCCCCCCEECCCCC | 32.65 | 21955146 | |
62 | Phosphorylation | RPEKKRVTHNPMIQK CCCCCCCCCCCCCHH | 21.70 | 28555341 | |
73 | Phosphorylation | MIQKTRDSGKQKAAY CCHHCHHCCCCCCCC | 44.60 | 26074081 | |
80 | Phosphorylation | SGKQKAAYGDLSSEE CCCCCCCCCCCCCHH | 18.94 | 20201521 | |
84 | Phosphorylation | KAAYGDLSSEEEEEN CCCCCCCCCHHHHHC | 40.21 | 20201521 | |
85 | Phosphorylation | AAYGDLSSEEEEENE CCCCCCCCHHHHHCC | 57.22 | 20201521 | |
95 | Phosphorylation | EEENEPESLGVVYKS HHHCCCHHHCEEEEE | 40.93 | 23927012 | |
100 | Phosphorylation | PESLGVVYKSTRSAK CHHHCEEEEECCCCC | 9.23 | 23927012 | |
102 | Phosphorylation | SLGVVYKSTRSAKPV HHCEEEEECCCCCCC | 16.03 | 26074081 | |
103 | Phosphorylation | LGVVYKSTRSAKPVG HCEEEEECCCCCCCC | 25.21 | 26074081 | |
105 | Phosphorylation | VVYKSTRSAKPVGPE EEEEECCCCCCCCHH | 40.51 | 26074081 | |
107 | Acetylation | YKSTRSAKPVGPEDM EEECCCCCCCCHHHC | 41.29 | 23954790 | |
107 | Sumoylation | YKSTRSAKPVGPEDM EEECCCCCCCCHHHC | 41.29 | - | |
107 | Sumoylation | YKSTRSAKPVGPEDM EEECCCCCCCCHHHC | 41.29 | - | |
117 | Phosphorylation | GPEDMGATAVYELDT CHHHCCCEEEEECCC | 15.78 | 21945579 | |
120 | Phosphorylation | DMGATAVYELDTEKE HCCCEEEEECCCCHH | 14.33 | 21945579 | |
124 | Phosphorylation | TAVYELDTEKERDAQ EEEEECCCCHHHHHH | 62.67 | 21945579 | |
126 | Ubiquitination | VYELDTEKERDAQAI EEECCCCHHHHHHHH | 61.21 | 24816145 | |
137 | Phosphorylation | AQAIFERSQKIQEEL HHHHHHHHHHHHHHH | 28.73 | 28555341 | |
139 | Sumoylation | AIFERSQKIQEELRG HHHHHHHHHHHHHCC | 47.83 | - | |
139 | Ubiquitination | AIFERSQKIQEELRG HHHHHHHHHHHHHCC | 47.83 | 29967540 | |
139 | Sumoylation | AIFERSQKIQEELRG HHHHHHHHHHHHHCC | 47.83 | - | |
147 | Ubiquitination | IQEELRGKEDDKIYR HHHHHCCCCCCHHHH | 52.08 | 29967540 | |
151 | Sumoylation | LRGKEDDKIYRGINN HCCCCCCHHHHHHHH | 54.69 | - | |
151 | Sumoylation | LRGKEDDKIYRGINN HCCCCCCHHHHHHHH | 54.69 | - | |
153 | Phosphorylation | GKEDDKIYRGINNYQ CCCCCHHHHHHHHHH | 14.45 | 22817900 | |
159 | Phosphorylation | IYRGINNYQKYMKPK HHHHHHHHHHHCCCC | 11.24 | - | |
161 | Sumoylation | RGINNYQKYMKPKDT HHHHHHHHHCCCCCC | 36.63 | - | |
161 | Acetylation | RGINNYQKYMKPKDT HHHHHHHHHCCCCCC | 36.63 | 25953088 | |
161 | Sumoylation | RGINNYQKYMKPKDT HHHHHHHHHCCCCCC | 36.63 | - | |
162 | Phosphorylation | GINNYQKYMKPKDTS HHHHHHHHCCCCCCC | 8.54 | 28258704 | |
166 | Sumoylation | YQKYMKPKDTSMGNA HHHHCCCCCCCCCCC | 69.03 | - | |
166 | Sumoylation | YQKYMKPKDTSMGNA HHHHCCCCCCCCCCC | 69.03 | - | |
168 | Phosphorylation | KYMKPKDTSMGNASS HHCCCCCCCCCCCCC | 27.09 | 20068231 | |
169 | Phosphorylation | YMKPKDTSMGNASSG HCCCCCCCCCCCCCC | 34.52 | 25159151 | |
174 | Phosphorylation | DTSMGNASSGMVRKG CCCCCCCCCCCEECC | 31.27 | - | |
175 | Phosphorylation | TSMGNASSGMVRKGP CCCCCCCCCCEECCC | 28.62 | - | |
180 | Sumoylation | ASSGMVRKGPIRAPE CCCCCEECCCCCCCH | 58.59 | - | |
180 | Sumoylation | ASSGMVRKGPIRAPE CCCCCEECCCCCCCH | 58.59 | - | |
192 | Phosphorylation | APEHLRATVRWDYQP CCHHHCEEEECCCCC | 12.27 | - | |
197 | Phosphorylation | RATVRWDYQPDICKD CEEEECCCCCCCCCC | 18.26 | 28796482 | |
216 | Phosphorylation | GFCGFGDSCKFLHDR CCCCCCCCCCCCCCC | 21.42 | 24719451 | |
227 | Sumoylation | LHDRSDYKHGWQIER CCCCCCCCCCEEEEE | 40.40 | - | |
227 | Sumoylation | LHDRSDYKHGWQIER CCCCCCCCCCEEEEE | 40.40 | - | |
241 | Phosphorylation | RELDEGRYGVYEDEN EEECCCCCEEEECCC | 23.07 | 28796482 | |
244 | Phosphorylation | DEGRYGVYEDENYEV CCCCCEEEECCCCCC | 17.19 | 23927012 | |
249 | Phosphorylation | GVYEDENYEVGSDDE EEEECCCCCCCCCCC | 15.22 | 23927012 | |
253 | Phosphorylation | DENYEVGSDDEEIPF CCCCCCCCCCCCCCE | 47.25 | 25159151 | |
268 | Phosphorylation | KCFICRQSFQNPVVT EEEEECHHCCCCHHH | 14.95 | 25159151 | |
316 | Sumoylation | PAKELIAKLEKHRAT HHHHHHHHHHHHHCC | 50.62 | - | |
316 | Sumoylation | PAKELIAKLEKHRAT HHHHHHHHHHHHHCC | 50.62 | - | |
323 | Phosphorylation | KLEKHRATGEGGASD HHHHHHCCCCCCCCC | 35.40 | 25159151 | |
329 | Phosphorylation | ATGEGGASDLPEDPD CCCCCCCCCCCCCCC | 42.85 | 25159151 | |
343 | Phosphorylation | DEDAIPIT------- CCCCCCCC------- | 27.49 | 21406692 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of R113A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of R113A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of R113A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SF3B2_HUMAN | SF3B2 | physical | 22365833 | |
CCAR1_HUMAN | CCAR1 | physical | 22365833 | |
RBM39_HUMAN | RBM39 | physical | 22365833 | |
ILF3_HUMAN | ILF3 | physical | 22365833 | |
U520_HUMAN | SNRNP200 | physical | 22365833 | |
RED_HUMAN | IK | physical | 22365833 | |
CARME_HUMAN | C9orf41 | physical | 28514442 | |
ACSF4_HUMAN | AASDH | physical | 28514442 | |
CSK22_HUMAN | CSNK2A2 | physical | 28514442 | |
CSK21_HUMAN | CSNK2A1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
300953 | Trichothiodystrophy 5, non-photosensitive (TTD5) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6; TYR-80; SER-84; SER-85 AND SER-253, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84 AND SER-253, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6; TYR-80; SER-84; SER-85 AND SER-253, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84; SER-85 AND SER-253,AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-80 AND SER-85, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43; SER-45; SER-46;SER-47; THR-52; SER-84; SER-85 AND SER-253, AND MASS SPECTROMETRY. |